Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?

American Journal of Tropical Medicine and Hygiene

Volumn 73, Issue 2, 2005, Pages 232-233

  Mccarthy, James ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; ANTIFILARIAL AGENT; ANTIMALARIAL AGENT; BENZIMIDAZOLE DERIVATIVE; CHLOROQUINE; DIETHYLCARBAMAZINE; FANSIDAR; IVERMECTIN; PYRIMETHAMINE; SULFADOXINE;

CESTODIASIS; DRUG POTENTIATION; EDITORIAL; FILARIASIS; GENOTYPE; HELMINTHIASIS; HUMAN; INFECTION CONTROL; MALARIA; MULTIDRUG RESISTANCE; NEMATODIASIS; NONHUMAN; PARASITE; TREATMENT OUTCOME; WORM INFECTION; WUCHERERIA BANCROFTI;

WUCHERERIA BANCROFTI;

EID: 24644524610     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2005.73.232     Document Type: Editorial

References (10)

1. CDC Recommendations of the International Task Force for Disease Eradication, 1993. MMWR Recomm Rep 42(RR-16): 1-38.
2. Gyapong JO, Kumaraswami V, Biswas G, Ottesen EA, 2005. Treatment strategies underpinning the global programme to eliminate lymphatic filariasis. Expert Opin Pharmacother 6: 179-200.
3. Wolstenholme AJ, Fairweather I, Prichard R, von Samson-Himmelstjerna G, Sangster NC, 2004. Drug resistance in veterinary helminths. Trends Parasitol 20: 469-476.
4. Eberhard ML, Lammie PJ, Dickinson CM, Roberts JM, 1991. Evidence of nonsusceptibility to diethylcarbamazine in Wuchereria bancrofti. J Infect Dis 163: 1157-1160.
5. Dreyer G, Addiss D, Santos A, Figueredo-Silva J, Noroes J, 1998. Direct assessment in vivo of the efficacy of combined single-dose ivermectin and diethylcarbamazine against adult Wuchereria bancrofti. Trans R Soc Trop Med Hyg 92: 219-222.
6. Awadzi K, Boakye DA, Edwards G, Opoku NO, Attah SK, Osei-Atweneboana MY, Lazdins-Helds JK, Ardrey AE, Addy ET, Quartey BT, Ahmed K, Boatin BA, Soumbey-Alley EW, 2004. An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasisendemic foci in Ghana. Ann Trop Med Parasitol 98: 231-249.
7. Schwab AE, Boakye DA, Kyelem D, Prichard RK, 2005. Detection of benzimidazole resistance-associated mutations in the filarial nematode Wuchereria bancrofti and evidence for selection by albendazole and ivermectin combination treatment. Am J Trop Med Hyg 73: 234-238.
8. De Clercq D, Sacko M, Behnke J, Gilbert F, Dorny P, Vercruysse J, 1997. Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali. Am J Trop Med Hyg 57: 25-30.
9. Albonico M, Wright V, Bickle Q, 2004. Molecular analysis of the beta-tubulin gene of human hookworms as a basis for possible benzimidazole resistance on Pemba Island. Mol Biochem Parasitol 134: 281-284.
10. Drogemuller M, Failing K, Schnieder T, von Samson-Himmelstjerna G, 2004. Effect of repeated benzimidazole treatments with increasing dosages on the phenotype of resistance and the beta-tubulin codon 200 genotype distribution in a benzimidazole-resistant cyathostomin population. Vet Parasitol 123: 201-213.